Humana Inc. (HUM) shares surged 7.9% to $197.15 at the end of the last trading session, supported by above-average volume. This rise follows an average gain of 2.3% over the prior four weeks. Additionally, the Centers for Medicare & Medicaid Services (CMS) finalized an increase in Medicare Advantage payment rates for 2027 by 2.48%, a significant rise from the 0.09% proposed earlier, enhancing revenue prospects for Humana, which reported 5.8 million Medicare Advantage members as of 2025.
Humana is expected to release its quarterly earnings report soon, predicting earnings of $9.89 per share, reflecting a year-over-year decrease of 14.6%. Projected revenues stand at $39.45 billion, an increase of 22.8% from the previous year. Recent revisions have raised earnings estimates by 1.1% over the past month, which typically correlates with stock price appreciation, suggesting potential future growth for HUM.
